Gabapentin diversion and misuse in the United States from a law enforcement perspective: Diversion rates and qualitative research findings

Similar documents
Gabapentin diversion and misuse: Data from law enforcement and substance users

Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E.

A National Perspective on the Abuse and Diversion of Prescription Drugs

Post-Marketing Surveillance: Lessons Learned and Recommendations for the Future

Key points. o Potential for nonmedical use, abuse, and diversion of new products

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

Key points. Background

BENZODIAZEPINE DEPENDENCE AMONG MULTIDRUG USERS IN THE CLUB SCENE. Steven P. Kurtz and Mance E. Buttram

Prescription Opioid Dependence and Addiction: Experience in the United States

Postmarketing Surveillance of Prescription Drug Abuse

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Diversion, misuse and trafficking of methadone and buprenorphine

RAPID Analysis of Routes of Administration: Oral to Non-Oral Transitions

Challenges in Conducting Postmarketing Abuse Investigations

GOVERNMENT S ROLE IN ADDRESSING PRESCRIPTION DRUG ABUSE

The Evolution of Abuse Deterrent Drug Formulations: Testing Effectiveness from the Benchtop to the Real World

Trends in Opioid Analgesic Abuse and Mortality in the United States

PREVENTION. Carroll County Health Department. Bureau of Prevention, Wellness and Recovery

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

Virtual Mentor American Medical Association Journal of Ethics April 2014, Volume 16, Number 4:

ACCG Mental Health Summit

Category 4 Can we prove that ADF opioids really are?

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Abuse, Misuse, and Diversion of Prescription Opioids: Evaluating the Problem and Proposed Solutions

RADARS System International Pre-Symposium 11 May Global Insights in Prescription Drug Misuse

Understanding and Combating the Heroin Epidemic

Richard C. Dart, MD, PhD Executive Director, RADARS System Denver Health and Hospital Authority

Opioid Deaths Quadruple Since 1999

Opioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities

Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids

Diversion, Misuse and Trafficking of Methadone and Buprenorphine in the US and Europ

Discuss the recent spread of opioid misuse. Discuss the rise of the current opioid crisis, a national addiction/overdose problem

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

What is the strategy?

AVOIDING PHYSICIAN STRESS IN MEDICAL PAIN MANAGEMENT

Prescription Painkiller Abuse in Wisconsin Sharing a Dose of Reality. Brad Schimel Wisconsin Attorney General

Strategies to Manage The Opioid Crisis

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

The Opioid Epidemic: State Trends in Opioid-Related Overdose Deaths from 2000 to 2015

Neurontin drug class. Search

End the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl. AGENCY: Drug Enforcement Administration, Department of Justice

Review of Controlled Drugs and Substances Act

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Opioids drive continued increase in drug overdose deaths

Federal Response. Rx Abuse & Diversion Current Trends. Pharmaceutical Drug Diversion 3/31/2017

REAL TIME MONITORING OF PRESCRIPTION MEDICINES BEING A HEALTHY STATE

Evolution of the Opioid Epidemic

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Attitudes Toward Medication-Assisted Treatment Within a Drug Court Program. Caroline Allison. Dr. Kathleen Moore, Ph.D.

Schedules of Controlled Substances: Temporary Placement of U into. AGENCY: Drug Enforcement Administration, Department of Justice.

Addressing the Opioid Epidemic in Tennessee

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC:

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

High-Decile Prescribers: All Gain, No Pain?

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

Lessons Learned from the US Prescription Opioid Abuse Epidemic

AATOD Fact Sheet. Medication-Assisted Treatment for Opioid Use Disorder in the Justice System October 2017

Medicare Advantage Outreach and Education Bulletin

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative

25/03/2014. Workshop Overview. Hot Topics in FDA Regulations and Pharmacotherapy Research that Impact Patient Care:

Opioid Addiction Statistics

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Follow this and additional works at: Part of the Substance Abuse and Addiction Commons

Opioid Review and MAT Clinic- Diversion

Top 10 narcotic pain pills

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Trends in Opioid Analgesic Abuse and Mortality in Europe

DEA: Combating the Supply

Table of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004

Epidemiologic Data on Opioid Use: Changing Problems

Opioid Use and Other Trends

Prescription Drug Abuse: Prevention and Treatment Across the Continuum of Care

Mosaic approach for monitoring Healthy People 2020 objectives:

Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy

Finding solutions. Aetna s comprehensive strategy to combat the opioid epidemic

Ahsan U. Rashid, M.D., F.A.C.P.

A LOOK AT ABUSE-DETERRENT OPIOIDS

A nation in pain: Focus on Medicaid

Washington State s Overdose Epidemic

Pennsylvania Prescription Drug Monitoring Program Trends,

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

Medical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses

RADARS R SYSTEM INTERNATIONAL PRE-SYMPOSIUM. International Landscape of Prescription Medication Misuse

Ranked in the top 10% in: -Low percent of adults reporting fair or poor health

Original Research Article Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?pme_

The Opioid Epidemic: National Trends in Opioid-Related Overdose Deaths from 2000 to 2015

Presentation Overview

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

[ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] Macomb County Office of Substance Abuse. A Focus on Heroin and Prescription Drug Abuse

Coalition Strategies Across The Continuum of Care

Evolution of the Opioid Epidemic

The Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

Opioid Review and MAT Clinic CDC Guidelines

Overdoses of pain medications and heroin rise dramatically in the Finger Lakes

Opioid Overdose in Oregon Report to the Legislature

Transcription:

Gabapentin diversion and misuse in the United States from a law enforcement perspective: Diversion rates 2002-2015 and qualitative research findings Mance E. Buttram, PhD Steven P. Kurtz, PhD 2 nd European Conference on Addictive Behaviours and Dependencies 24-26 October 2017 This research was supported by a contract from Denver Health and Hospital Authority

Gabapentin ɣ-aminobutyric acid (GABA)-analogue Treatment of epilepsy and neuralgia Prescribed off-label Low addictive liability level Prescription required Not scheduled under CSA Brands Neurontin, Horizant, Gralise

Gabapentin diversion Prescription drug diversion involves the unlawful channeling of regulated pharmaceuticals from legal sources to the illicit marketplace. Doctor shopping Shared medication from family / friends Direct trade / sale in street markets Theft Inciardi, et al. (2007)

Gabapentin misuse

Aims Examine gabapentin diversion National sample of law enforcement / regulatory agencies 2002-2015 Qualitative data on gabapentin misuse

Methods RADARS Drug Diversion Program Quarterly survey of Rx drug diversion Includes approximately 250 investigators Covers 1/3 of the total U.S. population Qualitative questionnaire April 2016 Have you seen or heard anything about increases in the abuse or diversion of gabapentin in your jurisdiction? If so, can you please comment on the characteristics of abusers, modes of diversion, and street value of the drugs?

Rates of gabapentin diversion (per 100,000) by quarter, 2002-2015 0.03 0.025 0.02 0.015 0.01 0.005 0 1Q2002 3Q2002 1Q2003 3Q2003 1Q2004 3Q2004 1Q2005 3Q2005 1Q2006 3Q2006 1Q2007 3Q2007 1Q2008 3Q2008 1Q2009 3Q2009 1Q2010 3Q2010 1Q2011 3Q2011 1Q2012 3Q2012 1Q2013 3Q2013 1Q2014 3Q2014 1Q2015 3Q2015

Qualitative findings Related to Rx opioids / heroin Many abusers stated they would take it with opioids to increase the duration of the high. Tennessee [Gabapentin] has been abused in conjunction with Suboxone (buprenorphine). Kentucky It is our understanding that heroin users are mixing a combination of gabapentin and heroin and injecting the compound. Alabama Drug users have been mixing gabapentin and heroin together and injecting. - Louisiana

Qualitative findings Diversion We had two cases this quarter where gabapentin was reported stolen. Idaho I had an overdose death of a 26 year old female she was doctor shopping for gabapentin. Georgia I did notice [gabapentin being an issue] when looking at my doctor shoppers and larceny of pill reports. North Carolina We bought gabapentin once in the past year; sold via Craigslist. California

Qualitative findings Street value Many patients have learned of its street value and are selling or trading it for narcotics. Kentucky Street value is about $10.00 a pill. Michigan

Discussion Gabapentin diversion rates increased from 0 cases in 2002 to.027 cases (per 100,000) in 2015 Compare to:.021 cases for OxyContin in 2015 2.5 cases for 6 Rx opioids in 2015 Gabapentin is: being used in conjunction with Rx opioids combined with heroin and injected Dart, et al. (2015); Severtson, et al. (2016)

Discussion Finding supports growing evidence of misuse: 15-26% of Rx opioid misusers Up to 65% of individuals with a gabapentin prescription 2,950% increase in gabapentin misuse among Rx opioid misusers in Kentucky Bastiens, et al. (2016); Klein-Schwartz, et al (2003); Smith, et al. (2015); Wilens, et al. (2015)

Next steps Additional epidemiologic research Research conducted among gabapentin misusers Post-marketing surveillance of diversion Bastiens, et al. (2016); Klein-Schwartz, et al (2003); Smith, et al. (2015); Wilens, et al. (2015)

References Bastiaens, L., Galus, J., & Mazur, C. (2016). Abuse of gabapentin is associated with opioid addiction. Psychiatric Quarterly, 87(4), 763-767. Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher- Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241-248. Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug involved club and street based populations. Pain Medicine, 8(2), 171-183. Klein-Schwartz, W., Shepherd, J. G., Gorman, S., & Dahl, B. (2003). Characterization of gabapentin overdose using a poison center case series. Journal of Toxicology: Clinical Toxicology, 41(1), 11-15. Severtson, S. G., Ellis, M. S., Kurtz, S. P., Rosenblum, A., Cicero, T. J., Parrino, M. W.,... & Green, J. L. (2016). Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug and alcohol dependence, 168, 219-229. Wilens, T., Zulauf, C., Ryland, D., Carrellas, N., & Catalina Wellington, I. (2014). Prescription medication misuse among opioid dependent patients seeking inpatient detoxification. The American journal on addictions.

Mance E. Buttram mance.buttram@nova.edu arsh.nova.edu